Inhibiting GLS in IDH1-mut glioma cells, in which 2-HG already suppresses BCAT, significantly impairs their fitness by lowering glutamate, glutathione, and resistance to oxidative stress in vitro and to radiation in vitro and in vivo [12]. The gene discussed is IDH1; the disease is glioma.